Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 08, 2025 01:15 ET | Source: Novartis Pharma AG

Novartis receives approval for first malaria medicine for newborn babies and young infants

Coartem® (artemether-lumefantrine) Baby becomes first malaria treatment approved for newborn babies and young infants Rapid approvals in eight African countries now expected under a special global...
April 11, 2024 16:30 ET | Source: PaxMedica, Inc.

PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submission

TARRYTOWN, New York, April 11, 2024 (GLOBE NEWSWIRE) -- via IBN – PaxMedica, Inc. (NASDAQ:PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, today...
October 26, 2021 15:41 ET | Source: Kainomyx Inc.

Kainomyx Announces New Funding to Advance Programs Focused on Malaria and Other Parasitic Diseases

PALO ALTO, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Kainomyx, Inc., founded in September 2019 and financed with $7.5M in May 2020, announced a new round of funding of $7.97M to advance its programs...
February 17, 2021 01:15 ET | Source: Novartis International AG

Novartis and the Bill & Melinda Gates Foundation collaborate to discover and develop an accessible in vivo gene therapy for sickle cell disease

Project brings together Novartis drug discovery and gene therapy expertise and funding support from the Gates Foundation Agreement aims to address disparity in access to treatments and to prioritize...
July 10, 2017 05:00 ET | Source: BCC Research

Tropical Diseases: Prevention, Care and Cure

Wellesley, Mass., July 10, 2017 (GLOBE NEWSWIRE) -- A new BCC Research report examines a growing need for treatment of prevention of tropical diseases and the impact on medical research that is...